Catalent is up 23.7%, or $13.29 to $69.34.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CTLT:
- CTLT Soars on Danaher Interest; Will Publish Q2 Numbers Tomorrow
- Premium required for any Catalent-Danaher deal ‘up for debate,’ says BofA
- Danaher has expressed takeover interest in Catalent, Bloomberg says
- Catalent price target lowered to $58 from $62 at Barclays
- Catalent appoints Zayas as SVP, Operations, Biologics North America